Overview
Triphalangeal thumb-polysyndactyly syndrome (TPTPS), also known as preaxial polydactyly type II or polysyndactyly with triphalangeal thumb, is a rare congenital limb malformation characterized by the presence of a triphalangeal thumb (a thumb with three phalanges instead of the normal two, giving it a finger-like appearance) combined with preaxial polydactyly (extra digits on the thumb side of the hand) and variable syndactyly (fusion of digits). The condition primarily affects the skeletal and musculoskeletal systems, specifically the hands and sometimes the feet. The thumbs may appear long and finger-like due to the extra phalanx, and in some cases, affected individuals may have duplicated thumbs or additional preaxial digits. Foot involvement can include preaxial polydactyly of the toes and syndactyly. The severity and specific features can vary considerably, even among members of the same family. This syndrome is caused by mutations in a regulatory region (the ZRS, or zone of polarizing activity regulatory sequence) located within intron 5 of the LMBR1 gene on chromosome 7q36. This regulatory element controls the expression of the SHH (Sonic Hedgehog) gene, which plays a critical role in limb patterning during embryonic development. Point mutations or duplications in this region lead to ectopic expression of SHH in the anterior limb bud, resulting in the characteristic preaxial limb anomalies. Treatment is primarily surgical and is tailored to the specific anatomical abnormalities present in each individual. Surgical correction may include removal of extra digits (polydactyly reduction), separation of fused digits (syndactyly release), and reconstruction of the thumb to improve function and appearance. Occupational therapy may be recommended following surgery to optimize hand function. Genetic counseling is advised for affected families given the autosomal dominant inheritance pattern. The prognosis is generally good, as the condition does not typically affect other organ systems or life expectancy, and surgical outcomes are usually favorable for improving hand function.
Also known as:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Triphalangeal thumb-polysyndactyly syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Triphalangeal thumb-polysyndactyly syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Triphalangeal thumb-polysyndactyly syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Triphalangeal thumb-polysyndactyly syndrome.
Community
No community posts yet. Be the first to share your experience with Triphalangeal thumb-polysyndactyly syndrome.
Start the conversation →Latest news about Triphalangeal thumb-polysyndactyly syndrome
No recent news articles for Triphalangeal thumb-polysyndactyly syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Triphalangeal thumb-polysyndactyly syndrome
What is Triphalangeal thumb-polysyndactyly syndrome?
Triphalangeal thumb-polysyndactyly syndrome (TPTPS), also known as preaxial polydactyly type II or polysyndactyly with triphalangeal thumb, is a rare congenital limb malformation characterized by the presence of a triphalangeal thumb (a thumb with three phalanges instead of the normal two, giving it a finger-like appearance) combined with preaxial polydactyly (extra digits on the thumb side of the hand) and variable syndactyly (fusion of digits). The condition primarily affects the skeletal and musculoskeletal systems, specifically the hands and sometimes the feet. The thumbs may appear long a
How is Triphalangeal thumb-polysyndactyly syndrome inherited?
Triphalangeal thumb-polysyndactyly syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Triphalangeal thumb-polysyndactyly syndrome typically begin?
Typical onset of Triphalangeal thumb-polysyndactyly syndrome is neonatal. Age of onset can vary across affected individuals.